Comparative efficacy of commonly used first-line chemotherapy regimens in advanced pancreatic cancer: A network meta-analysis.

被引：0
|
作者：
Haddad, Philip A. [1 ]
Gallagher, Kevin Michael [1 ]
Hammoud, Dalia [1 ]
机构：
[1] Overton Brooks VAMC, LSUHSC Shreveport, Feist Weiller Canc Ctr, Shreveport, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
    Wu, Dong-Mei
    Wang, Yong-Jian
    Fan, Shao-Hua
    Zhuang, Juan
    Zhang, Zi-Feng
    Shan, Qun
    Han, Xin-Rui
    Wen, Xin
    Li, Meng-Qiu
    Hu, Bin
    Sun, Chun-Hui
    Bao, Ya-Xing
    Xiao, Hai-Juan
    Yang, Lin
    Lu, Jun
    Zheng, Yuan-Lin
    ONCOTARGET, 2017, 8 (59) : 100668 - 100677
  • [2] Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan A Systematic Review and Network Meta-analysis
    Takumoto, Yuki
    Sasahara, Yuriko
    Narimatsu, Hiroto
    Akazawa, Manabu
    JAMA NETWORK OPEN, 2022, 5 (01)
  • [3] Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer
    Lin, Kun-, I
    Yang, Jia-Lian
    Lin, Yu-Chao
    Chou, Che-Yi
    Chen, Jin-Hua
    Hung, Chin-Chuan
    CANCERS, 2019, 11 (11)
  • [4] The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis
    ter Veer, Emil
    Mohammad, Nadia Haj
    van Valkenhoef, Gert
    Ngai, Lok Lam
    Mali, Rosa M. A.
    Anderegg, Maarten C.
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (10):
  • [5] Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and network meta-analysis
    Mastrantoni, L.
    Beccia, V.
    Chiaravalli, M.
    Di Bello, A.
    Spring, A.
    Barone, D.
    Schietroma, F.
    Maratta, M. G.
    Trovato, G.
    Bagala, C.
    Bensi, M.
    Alfieri, S.
    Quero, G.
    Tortora, G.
    Salvatore, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S920 - S920
  • [6] Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer A network meta-analysis
    Qu, Chang-Ping
    Sun, Gui-Xia
    Yang, Shao-Qin
    Tian, Jun
    Si, Jin-Ge
    Wang, Yi-Feng
    MEDICINE, 2017, 96 (02)
  • [7] First-line doublet or triplet chemotherapy for advanced esophagogastric cancer: A systematic review and meta-analysis.
    Mohammad, Nadia Haj
    ter Veer, Emil
    Ngai, Lok Lam
    Mali, Rosa
    van Oijen, Martijn G. H.
    Van Laarhoven, Hanneke W. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
    Zhang, Shuisheng
    Xie, Weimin
    Zou, Yinghua
    Xie, Shuanghua
    Zhang, Jianwei
    Yuan, Wei
    Ma, Jie
    Zhao, Jiuda
    Zheng, Cuiling
    Chen, Yingtai
    Wang, Chengfeng
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5965 - 5978
  • [9] Efficacy of different chemotherapy regimens in treatment of advanced or metastatic pancreatic cancer: A network meta-analysis
    Zhang, Shu-Hua
    Liu, Gui-Feng
    Li, Xue-Feng
    Liu, Lin
    Yu, Shao-Nan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (04) : 3352 - 3374
  • [10] Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis
    Shu Liu
    Heung Yan Wong
    Li Xie
    Yoojin Kim
    Danhua Shu
    Beishi Zheng
    Naxin Liu
    Chungen Xing
    Xiaolei Chen
    Qiantong Dong
    Scientific Reports, 12
12345